Tag Archives: iron

Cost-Effective Method For Hydrogen Fuel Production

Nanoparticles composed of nickel and iron have been found to be more effective and efficient than other, more costly materials when used as catalysts in the production of hydrogen fuel through water electrolysis. The discovery was made by University of Arkansas researchers Jingyi Chen, associate professor of physical chemistry, and Lauren Greenlee, assistant professor of chemical engineering, as well as colleagues from Brookhaven National Lab and Argonne National Lab. The researchers demonstrated that using nanocatalysts composed of nickel and iron increases the efficiency of water electrolysis, the process of breaking water atoms apart to produce hydrogen and oxygen and combining them with electrons to create hydrogen gas.

Chen and her colleagues discovered that when nanoparticles composed of an iron and nickel shell around a nickel core are applied to the process, they interact with the hydrogen and oxygen atoms to weaken the bonds, increasing the efficiency of the reaction by allowing the generation of oxygen more easily. Nickel and iron are also less expensive than other catalysts, which are made from scarce materials.

This marks a step toward making water electrolysis a more practical and affordable method for producing hydrogen fuel. Current methods of water electrolysis are too energy-intensive to be effective.

Chen, Greenlee and their colleagues recently published their results in the journal Nanoscale.

Source: https://news.uark.edu/

How To Reverse Vascular Disease In Kidney Failure

By loading a chelation drug into a nano-sized homing device, researchers at Clemson University have reversed in an animal model the deadliest effects of chronic kidney disease, which kills more people in the United States each year than breast or prostate cancer. When kidneys stop working properly, calcium builds up in artery tissue, leading to heart disease. Although nearly half a million Americans receive kidney dialysis, heart disease is the leading cause of death for people with chronic kidney disease.

Human kidney cross section on scientific background

The findings are very exciting scientifically, but also for the thousands of patients who could potentially benefit from this technology one day,” said Naren Vyavahare, professor of bioengineering at Clemson and the principal investigator of the research.

Chelation, a method of removing metals such as iron and lead from the body, has been used experimentally for some people with heart disease. The therapy is not approved by the Food and Drug Administration, but the National Institutes of Health has sponsored two large-scale, multi-center studies using ethylene diamine tetra-acetic acid, or EDTA, as chelation therapy for people with heart disease.

In clinical studies, EDTA is included in an infusion that circulates through the body; it’s systemic and non-specific. This method of chelation has shown good results in improving heart function, especially in diabetic patients, Vyavahare said. But EDTA infusion therapy is arduous (it requires 40 infusions over a period of a year), and it can cause side effects, including a depletion of calcium from the blood and from bone.

Now, in a paper published in Scientific Reports, a Nature publication, Vyavahare’s team describes how they developed an animal model that mimics a human’s chronic kidney disease. Animals were treated either with EDTA infusions, like in the NIH human trials, or with EDTA enclosed in a nanoparticle coupled with an antibody that seeks out damaged elastin. In animals that received the targeted therapy, calcium buildup was destroyed, without causing side effects, better than with EDTA infusions alone. Moreover, the calcification did not come back up to four weeks after the last injection, even though other signs of chronic kidney disease were present.

Source: http://newsstand.clemson.edu/

2D Material Revolutionizes Solar Fuel Generation

Following the isolation of graphene in 2004, a race began to synthesize new two-dimensional materials. 2D materials are single-layer substances with a thickness of between one atom and a few nanometers (billionths of a meter). They have unique properties linked to their reduced dimensionality and play a key role in the development of nanotechnology and nanoengineering.

An international group of researchers including Brazilian scientists affiliated with the University of Campinas (UNICAMP) have succeeded in producing a new material with these characteristics.

The researchers extracted a 2D material they call hematene from ordinary iron ore like that mined in many parts of the world, including Brazil. The material is only three atoms thick and is thought to have enhanced photocatalytic properties.

International group of researchers including Brazilian scientists obtain new material from iron ore with application as a photocatalyst

The research was conducted at the Center for Computational Engineering and Sciences (CCES), one of the Research, Innovation and Dissemination Centers (RIDCs) funded by FAPESP, and during a research internship abroad that was also supported by FAPESP via a specific scholarship.

Douglas Soares Galvão, a researcher at CCES and one of the authors of the study, told Agência FAPESP about the discovery. “The material we synthesized can act as a photocatalyst to split water into hydrogen and oxygen, so that electricity can be generated from hydrogen, for example, as well as having several other potential applications,” he said.

The new material was exfoliated from hematite, one of the most common minerals on earth and the main source of iron, which is the cheapest metal, used in many products and above all to make steel.

Unlike carbon and its 2D form graphene, hematite is a non-van der Waals material, meaning it is held together by 3D bonding networks rather than by nonchemical and comparatively weaker atomic van der Waals interactions, which are noncovalent (they do not involve the sharing of one or more pairs of electrons by the atoms that participate in the bond).

Because it is a naturally occurring mineral, has highly oriented, large crystals and is a non-van der Waals material, the researchers believe that hematite is an excellent precursor for the exfoliation of novel 2D materials.

Most of the 2D materials synthesized to date were derived from samples of van der Waals solids. Non-van der Waals 2D materials with highly ordered atomic layers and large grains are still rare,” Galvão said.

Hematene was synthesized by the liquid-phase exfoliation of hematite ore in an organic solvent, N,N-dimethylformamide (DMF). Transmission electron microscopy confirmed the exfoliation and formation of hematene in single sheets with a thickness of only three iron and oxygen atoms (monolayer) and in randomly stacked sheets (bilayer).

The innovation is described in an article published in Nature Nanotechnology.

Source: http://agencia.fapesp.br/

 

Brain Metals Drive Alzheimer’s Progression

Alzheimer’s disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegenerative condition, by an international research collaboration including the University of Warwick.

Iron is an essential element in the brain, so it is critical to understand how its management is affected in Alzheimer’s disease. The advanced X-ray techniques that we used in this study have delivered a step-change in the level of information that we can obtain about iron chemistry in the amyloid plaques. We are excited to have these new insights into how amyloid plaque formation influences iron chemistry in the human brain, as our findings coincide with efforts by others to treat Alzheimer’s disease with iron-modifying drugs,” commented Dr Joanna Collingwood, from Warwick’s School of Engineering, who was part of a research team which characterised iron species associated with the formation of amyloid protein plaques in the human brainabnormal clusters of proteins in the brain. The formation of these plaques is associated with toxicity which causes cell and tissue death, leading to mental deterioration in Alzheimer’s patients.

They found that in brains affected by Alzheimer’s, several chemically-reduced iron species including a proliferation of a magnetic iron oxide called magnetite – which is not commonly found in the human brainoccur in the amyloid protein plaques. The team had previously shown that these minerals can form when iron and the amyloid protein interact with each other. Thanks to advanced measurement capabilities at synchrotron X-ray facilities in the UK and USA, including the Diamond Light Source I08 beamline in Oxfordshire, the team has now shown detailed evidence that these processes took place in the brains of individuals who had Alzheimer’s disease. They also made unique observations about the forms of calcium minerals present in the amyloid plaques.

The team, led by an EPSRC-funded collaboration between University of Warwick and Keele University – and which includes researchers from University of Florida and The University of Texas at San Antonio – made their discovery by extracting amyloid plaque cores from two deceased patients who had a formal diagnosis of Alzheimer’s. The researchers scanned the plaque cores using state-of-the-art X-ray microscopy at the Advanced Light Source in Berkeley, USA and at beamline I08 at the Diamond Light Source synchrotron in Oxfordshire, to determine the chemical properties of the minerals within them.

Source: https://warwick.ac.uk/

New Cathode Triples the Energy Storage of Lithium-Ion Batteries

As the demand for smartphones, electric vehicles, and renewable energy continues to rise, scientists are searching for ways to improve lithium-ion batteries—the most common type of battery found in home electronics and a promising solution for grid-scale energy storage. Increasing the energy density of lithium-ion batteries could facilitate the development of advanced technologies with long-lasting batteries, as well as the widespread use of wind and solar energy. Now, researchers have made significant progress toward achieving that goal. A collaboration led by scientists at the University of Maryland (UMD), the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory, and the U.S. Army Research Lab have developed and studied a new cathode material that could triple the energy density of lithium-ion battery electrodes

Lithium-ion batteries consist of an anode and a cathode,” said Xiulin Fan, a scientist at UMD and one of the lead authors of the paper. “Compared to the large capacity of the commercial graphite anodes used in lithium-ion batteries, the capacity of the cathodes is far more limited. Cathode materials are always the bottleneck for further improving the energy density of lithium-ion batteries.

Scientists at UMD synthesized a new cathode material, a modified and engineered form of iron trifluoride (FeF3), which is composed of cost-effective and environmentally benign elements—iron and fluorine. Researchers have been interested in using chemical compounds like FeF3 in lithium-ion batteries because they offer inherently higher capacities than traditional cathode materials.

The materials normally used in lithium-ion batteries are based on intercalation chemistry,” said Enyuan Hu, a chemist at Brookhaven and one of the lead authors of the paper. “This type of chemical reaction is very efficient; however, it only transfers a single electron, so the cathode capacity is limited. Some compounds like FeF3 are capable of transferring multiple electrons through a more complex reaction mechanism, called a conversion reaction.

The findings are published in Nature Communications.

Source: https://www.bnl.gov/

How To Deliver Drug Deep In The Brain

By learning how rabies virus travels in the brain, Anti-Parkinson’s drug can be delivered deep in the brain where currently the drugs are not able to reachRabies virus has the capability to trick the nervous system and cross the blood brain barrier. This trick could be used for drug design. Glycoprotein 29 present on the rabies virus is attached to a nanoparticle stuffed full of deferoxamine ( Anti-Parkinson’s medication) and injected into the brain to trick the brain.

Rabies virus may have some tricks to bypass the blood brain barrier, this trick can be used to treat disease that require drugs to effectively cross the blood brain barrier, finds a new study.

The researchers can now exploit rabies viruses machinery to deliver a Parkinson’s disease medication directly to the brain. Upon injection the nanoparticles grab excess iron and relieve symptoms. While the common cause of Parkinson’s disease is unknown, it has been proved that accumulation of iron in neurons is one of the commonest features of Parkinson’s disease.

Deferoxamine is a metal-grabbing compound and sop up the excess iron in patients. But a large quantity of this drug needs to reach the brain in order for them work.
To usher deferoxamine into the brain, the researchers Yan-Zhong Chang, Xin Lou, Guangjun Nie took advantage of a key part of the rabies virusGlycoprotein 29.
When they injected this iron-grabbing nanoparticles into mouse models of Parkinson’s disease, the iron levels dropped and this reduced brain damage caused by Parkinson’s disease.

The findings of this study is published in the ACS Nano journal.

Source: https://www.acs.org/